Venixxa.
The #1 doctor-recommended over-the-counter brand for mild-to-moderate chronic venous disease and hemorrhoids.¹
Venixxa Hemorrhoids
Rapid relief of signs and symptoms associated with acute and chronic hemorrhoidal episodes
Venixxa Healthy Legs
Relief of mild-to-moderate chronic venous disease symptoms
Safety Information:
Venixxa - Safety Information
RECOMMENDED USE: Helps to reduce lower leg edema associated with mild-to-moderate chronic venous disease. Helps to relieve signs and symptoms of mild-to moderate chronic venous disease such as varicose veins, pain in the legs, sensation of heaviness, sensation of swelling, fatigue and discomfort. Helps to reduce signs and symptoms associated with hemorrhoids, such as pain, bleeding, itching (pruritus), swelling (edema), anal discharge, discomfort, inflammation (proctitis), redness (erythema), and sensation of needing to pass stools (tenesmus). Helps to reduce the duration, intensity and recurrence of acute hemorrhoidal episodes.
CAUTIONS AND WARNINGS: Treatment should be avoided during pregnancy and breastfeeding. If you are taking prescription medication, consult a healthcare practitioner prior to use. For hemorrhoidal Disease: If symptoms persist or worsen, or if acute hemorrhoidal episode persists after 7 days of use, consult a healthcare practitioner. For hemorrhoidal disease : If hemorrhoids are accompanied by rectal bleeding (bloody stools sometimes look like black tar), or if you are experience a change in bowel habits, consult a healthcare practitioner. For chronic venous disease: If you suffer, or experience inflammation of the skin, thrombophlebitis or subcutaneous induration, severe pain, ulcers, sudden swelling of one or both legs, cardiac or renal insufficiency or disorder, consult a health care practitioner prior to use. For chronic venous disease: If symptoms persist or worsen, consult a healthcare practitioner.
KNOWN ADVERSE REACTIONS: Hypersensitivity/ allergy, gastrointestinal discomfort, dizziness, headache, malaise and skin reactions have been known to occur; in which case, discontinue use and consult a healthcare practitioner.
References:
- Based on iQvia data, 2023.
2024